Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells

M M Pascal, J V Forrester, R M Knott

Research output: Contribution to journalArticle

Abstract

Purpose. Diabetic retinopathy is a micro-angiopathy affecting predominantly small vessels of the retina. Clinical trials have demonstrated a strong association between tight glucose control and a reduction in the incidence and the severity of diabetic retinopathy. Transforming growth factor beta (TGF-beta) is involved in the control of endothelial cell proliferation, adhesion, and deposition of extracellular matrix, thus TGF-beta may play a role in the control of endothelial cell proliferation seen in the disease. We wished to investigate the regulation of transforming growth factor beta and its receptors (type I and II) in human retinal endothelial cells exposed to a range of glucose concentrations.

Methods. Human retinal endothelial cells were isolated from donor eyes, cultured in vitro and exposed to a range of glucose concentrations (0-25 mmol/l). TGF-beta protein and mRNA levels were determined by ELISA and Northern analysis, respectively. The binding affinities and TGF-beta receptor numbers were defined using a binding assay.

Results. Northern hybridisation and ELISA showed that after 8 hours, the level of TGF-beta mRNA and protein was significantly higher at 15mmol/l compared to 5, 20 or 25mmol/l 1. Binding assays showed that for high glucose (25 mmol/l), human retinal endothelial cells express a population of TGF-beta receptors with higher affinity for its ligand than at 5 or 15 mmol/l.

Conclusions. These results demonstrate that glucose regulates TGF-beta mRNA and protein production and also TGF-beta receptor expression in human retinal endothelial cells. Thus, the glucose-mediated changes that occur in diabetic patients may expose human retinal endothelial cells to potential angiogenic factors which may influence disease progression.

Original languageEnglish
Pages (from-to)162-170
Number of pages9
JournalCurrent Eye Research
Volume19
Publication statusPublished - 1999

Keywords

  • glucose
  • transforming growth factor-beta (TGF-beta)
  • TGF-beta receptors
  • diabetic retinopathy
  • retinal endothelial cells
  • human
  • DIABETIC-RETINOPATHY
  • GENE-EXPRESSION
  • GROWTH-FACTOR-BETA-1
  • INHIBITION
  • TGF-BETA-1
  • PROLIFERATION
  • ANGIOGENESIS
  • MODULATION
  • PERICYTES
  • COLLAGEN

Cite this

Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells. / Pascal, M M ; Forrester, J V ; Knott, R M .

In: Current Eye Research, Vol. 19, 1999, p. 162-170.

Research output: Contribution to journalArticle

@article{3d79c6e4bb7644a7917932f43429097b,
title = "Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells",
abstract = "Purpose. Diabetic retinopathy is a micro-angiopathy affecting predominantly small vessels of the retina. Clinical trials have demonstrated a strong association between tight glucose control and a reduction in the incidence and the severity of diabetic retinopathy. Transforming growth factor beta (TGF-beta) is involved in the control of endothelial cell proliferation, adhesion, and deposition of extracellular matrix, thus TGF-beta may play a role in the control of endothelial cell proliferation seen in the disease. We wished to investigate the regulation of transforming growth factor beta and its receptors (type I and II) in human retinal endothelial cells exposed to a range of glucose concentrations.Methods. Human retinal endothelial cells were isolated from donor eyes, cultured in vitro and exposed to a range of glucose concentrations (0-25 mmol/l). TGF-beta protein and mRNA levels were determined by ELISA and Northern analysis, respectively. The binding affinities and TGF-beta receptor numbers were defined using a binding assay.Results. Northern hybridisation and ELISA showed that after 8 hours, the level of TGF-beta mRNA and protein was significantly higher at 15mmol/l compared to 5, 20 or 25mmol/l 1. Binding assays showed that for high glucose (25 mmol/l), human retinal endothelial cells express a population of TGF-beta receptors with higher affinity for its ligand than at 5 or 15 mmol/l.Conclusions. These results demonstrate that glucose regulates TGF-beta mRNA and protein production and also TGF-beta receptor expression in human retinal endothelial cells. Thus, the glucose-mediated changes that occur in diabetic patients may expose human retinal endothelial cells to potential angiogenic factors which may influence disease progression.",
keywords = "glucose, transforming growth factor-beta (TGF-beta), TGF-beta receptors, diabetic retinopathy, retinal endothelial cells, human, DIABETIC-RETINOPATHY, GENE-EXPRESSION, GROWTH-FACTOR-BETA-1, INHIBITION, TGF-BETA-1, PROLIFERATION, ANGIOGENESIS, MODULATION, PERICYTES, COLLAGEN",
author = "Pascal, {M M} and Forrester, {J V} and Knott, {R M}",
year = "1999",
language = "English",
volume = "19",
pages = "162--170",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells

AU - Pascal, M M

AU - Forrester, J V

AU - Knott, R M

PY - 1999

Y1 - 1999

N2 - Purpose. Diabetic retinopathy is a micro-angiopathy affecting predominantly small vessels of the retina. Clinical trials have demonstrated a strong association between tight glucose control and a reduction in the incidence and the severity of diabetic retinopathy. Transforming growth factor beta (TGF-beta) is involved in the control of endothelial cell proliferation, adhesion, and deposition of extracellular matrix, thus TGF-beta may play a role in the control of endothelial cell proliferation seen in the disease. We wished to investigate the regulation of transforming growth factor beta and its receptors (type I and II) in human retinal endothelial cells exposed to a range of glucose concentrations.Methods. Human retinal endothelial cells were isolated from donor eyes, cultured in vitro and exposed to a range of glucose concentrations (0-25 mmol/l). TGF-beta protein and mRNA levels were determined by ELISA and Northern analysis, respectively. The binding affinities and TGF-beta receptor numbers were defined using a binding assay.Results. Northern hybridisation and ELISA showed that after 8 hours, the level of TGF-beta mRNA and protein was significantly higher at 15mmol/l compared to 5, 20 or 25mmol/l 1. Binding assays showed that for high glucose (25 mmol/l), human retinal endothelial cells express a population of TGF-beta receptors with higher affinity for its ligand than at 5 or 15 mmol/l.Conclusions. These results demonstrate that glucose regulates TGF-beta mRNA and protein production and also TGF-beta receptor expression in human retinal endothelial cells. Thus, the glucose-mediated changes that occur in diabetic patients may expose human retinal endothelial cells to potential angiogenic factors which may influence disease progression.

AB - Purpose. Diabetic retinopathy is a micro-angiopathy affecting predominantly small vessels of the retina. Clinical trials have demonstrated a strong association between tight glucose control and a reduction in the incidence and the severity of diabetic retinopathy. Transforming growth factor beta (TGF-beta) is involved in the control of endothelial cell proliferation, adhesion, and deposition of extracellular matrix, thus TGF-beta may play a role in the control of endothelial cell proliferation seen in the disease. We wished to investigate the regulation of transforming growth factor beta and its receptors (type I and II) in human retinal endothelial cells exposed to a range of glucose concentrations.Methods. Human retinal endothelial cells were isolated from donor eyes, cultured in vitro and exposed to a range of glucose concentrations (0-25 mmol/l). TGF-beta protein and mRNA levels were determined by ELISA and Northern analysis, respectively. The binding affinities and TGF-beta receptor numbers were defined using a binding assay.Results. Northern hybridisation and ELISA showed that after 8 hours, the level of TGF-beta mRNA and protein was significantly higher at 15mmol/l compared to 5, 20 or 25mmol/l 1. Binding assays showed that for high glucose (25 mmol/l), human retinal endothelial cells express a population of TGF-beta receptors with higher affinity for its ligand than at 5 or 15 mmol/l.Conclusions. These results demonstrate that glucose regulates TGF-beta mRNA and protein production and also TGF-beta receptor expression in human retinal endothelial cells. Thus, the glucose-mediated changes that occur in diabetic patients may expose human retinal endothelial cells to potential angiogenic factors which may influence disease progression.

KW - glucose

KW - transforming growth factor-beta (TGF-beta)

KW - TGF-beta receptors

KW - diabetic retinopathy

KW - retinal endothelial cells

KW - human

KW - DIABETIC-RETINOPATHY

KW - GENE-EXPRESSION

KW - GROWTH-FACTOR-BETA-1

KW - INHIBITION

KW - TGF-BETA-1

KW - PROLIFERATION

KW - ANGIOGENESIS

KW - MODULATION

KW - PERICYTES

KW - COLLAGEN

M3 - Article

VL - 19

SP - 162

EP - 170

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

ER -